137 related articles for article (PubMed ID: 1577849)
1. Prognostic significance of plasma prostaglandin E concentration in patients with head and neck cancer.
Klapan I; Katić V; Culo F; Cuk V
J Cancer Res Clin Oncol; 1992; 118(4):308-13. PubMed ID: 1577849
[TBL] [Abstract][Full Text] [Related]
2. Lipid-bound sialic acid, prostaglandin E and histamine in head and neck cancer.
Klapan I; Katić V; Culo F; Sabolović D; Cuk V; Fumić K; Simović S
Eur J Cancer; 1993; 29A(6):839-45. PubMed ID: 8484973
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of plasma PGE2 levels in pre- and post-operative patients with laryngeal carcinoma].
Li SZ; Liu H; Xu XL
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Mar; 14(3):106-7. PubMed ID: 12541407
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandins E and F in endocrine diarrheagenic syndromes.
Jaffe BM; Condon S
Ann Surg; 1976 Oct; 184(4):516-24. PubMed ID: 189708
[TBL] [Abstract][Full Text] [Related]
5. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
6. Production of prostaglandin E by squamous carcinoma of the head and neck and adenocarcinoma of gastrointestinal tissue.
Culo F; Klapan I; Katić V; Kolak T; Bakula B
Med Oncol Tumor Pharmacother; 1992; 9(1):35-9. PubMed ID: 1341318
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression and human cancer: role of prostaglandins.
Harvey HA; Allegra JC; Demers LM; Luderer JR; Brenner DE; Trautlein JJ; White DS; Gillin MA; Lipton A
Cancer; 1977 Jun; 39(6):2362-4. PubMed ID: 872034
[TBL] [Abstract][Full Text] [Related]
8. [CEA studies in squamous cell carcinomas of the head and neck].
Schröder M; Meyer T
HNO; 1986 Aug; 34(8):334-42. PubMed ID: 3759515
[TBL] [Abstract][Full Text] [Related]
9. Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study.
Marioni G; Blandamura S; Lionello M; Giacomelli L; Lovato A; Favaretto N; Breda S; Tealdo G; Guzzardo V; Ottaviano G; Staffieri A
Head Neck; 2014 Nov; 36(11):1534-40. PubMed ID: 23996283
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J
Anticancer Res; 2000; 20(5C):3975-81. PubMed ID: 11268487
[TBL] [Abstract][Full Text] [Related]
11. Elevated Levels of Urinary PGE-M Are Found in Tobacco Users and Indicate a Poor Prognosis for Oral Squamous Cell Carcinoma Patients.
Kekatpure VD; Bs N; Wang H; Zhou XK; Kandasamy C; Sunny SP; Suresh A; Milne GL; Kuriakose MA; Dannenberg AJ
Cancer Prev Res (Phila); 2016 Jun; 9(6):428-36. PubMed ID: 27045033
[TBL] [Abstract][Full Text] [Related]
12. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
13. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of postoperative wound infection on head and neck cancer.
Rodrigo JP; Suárez C
Otolaryngol Head Neck Surg; 1998 Feb; 118(2):272-5. PubMed ID: 9482566
[TBL] [Abstract][Full Text] [Related]
15. Plasma thromboxane A2 and prostacyclin concentrations in squamous cell carcinoma of the head and neck.
Slotman GJ
J Surg Oncol; 1988 May; 38(1):33-7. PubMed ID: 3287005
[TBL] [Abstract][Full Text] [Related]
16. Analysis of preoperative serum levels of MMP1, -2, and -9 in patients with site-specific head and neck squamous cell cancer.
Kalfert D; Ludvikova M; Topolcan O; Windrichova J; Malirova E; Pesta M; Celakovsky P
Anticancer Res; 2014 Dec; 34(12):7431-41. PubMed ID: 25503184
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
[TBL] [Abstract][Full Text] [Related]
19. Elevated arginine vasopressin levels in squamous cell cancer of the head and neck.
Talmi YP; Wolf GT; Hoffman HT; Krause CJ
Laryngoscope; 1996 Mar; 106(3 Pt 1):317-21. PubMed ID: 8614196
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
